Press Releases

02 May 2006

Karus Therapeutics appoints Simon Kerry as CEO

Karus Therapeutics, an emerging biotechnology company and University of Southampton spinout, focused on developing innovative therapeutics to treat cancer and heart disease, has announced the appointment of Simon Kerry as its Chief Executive Officer (CEO).

Read more

13 December 2005

Collaboration with Sareum Holdings

Karus Therapeutics is pleased to announce it has entered into a collaborative agreement with AIM-listed Sareum Holdings plc, a specialist structure-based drug discovery and services business. Sareum will provide computational chemistry expertise to support Karus's therapeutic discovery programmes based on inhibitors of histone deacetylase (HDAC). Financial terms of the agreement were not disclosed.

Read more

21 July 2005

Cancer and heart disease drug discovery company is latest spin-out from Southampton University

A new spin-out company from the University of Southampton is aiming to make the treatment of cancer and heart disease more patient friendly.

Read more